HeartBeam Inc (BEAT) Actualités

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks

Study Comparing 3D VECG Approach to Conventional 12L ECG Appeared in JACC: Advances, a Journal of the American College of Cardiology HeartBeam...

HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs

Experienced Biomedical Engineer Brings 12+ Years’ Experience in Regulatory Affairs and Quality Assurance for Medical Devices and Diagnostics with...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform...

Form 8-K - Current report

HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors

Renowned Vascular Physician and Researcher Brings Wealth of Clinical and Industry Experience to Board HeartBeam, Inc. (NASDAQ: BEAT), a cardiac...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report